Most cancers have many chromosomal abnormalities, both in number and in structure, whereas some show only a single aberration. In the era before molecular biology, cancer researchers, studying both human and animal cancers, proposed that a small number of events was needed for carcinogenesis. Evidence from the recent molecular era also indicates that cancers can arise from small numbers of events that affect common cell birth and death processes.
Your institute does not have access to this article
Open Access articles citing this article.
npj Precision Oncology Open Access 09 June 2022
Der Urologe Open Access 04 October 2021
Convergent evolution of a genomic rearrangement may explain cancer resistance in hystrico- and sciuromorpha rodents
npj Aging and Mechanisms of Disease Open Access 01 September 2021
Subscribe to Journal
Get full journal access for 1 year
only $4.92 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Get time limited or full article access on ReadCube.
All prices are NET prices.
Boveri, T. Zur Frage der Entstehung Maligner Tumoren (Gustav Fischer, Jena); English translation The Origin of Malignant Tumors by Boveri, M. (Williams and Wilkins, Baltimore, 1929, 1914).
von Hansemann, D. Über asymmetrische Zellteilung in Epithelkrebsen und deren biologische Bedeutung. Virchow's Arch. Path. Anat. 119, 299–326 (1890).
Balmain, A. Cancer genetics: from Boveri and Mendel to microarrays. Nature Rev. Cancer 1, 77–80 (2001).
Tyzzer, E. E. Tumor immunity. J. Cancer Res. 1, 125–156 (1916).
Muller, H. J. Artificial transmutation of the gene. Science 46, 84–87 (1927).
Muller, H. J. Radiation damage to the genetic material. Sci. Progress 7, 93–165, 481–493 (1951).
Cleaver, J. E. Defective repair replication of DNA in xeroderma pigmentosum. Nature 218, 652–656 (1968).
Berenblum, I. & Shubik, P. A new, quantitative, approach to the study of the stages of chemical carcinogenesis in the mouse's skin. Br. J. Cancer 1, 383–391 (1947).
Ames, B. N., Sims, P. & Grover, P. L. Epoxides of carcinogenic polycyclic hydrocarbons are frameshift mutagens. Science 176, 47–49 (1972).
Armitage, P. & Doll, R. The age distribution of cancer and a multi-stage theory of carcinogenesis. Br. J. Cancer 8, 1–12 (1954).
Nordling, C. E. A new theory on the cancer-inducing mechanism. Br. J. Cancer 6, 68–72 (1953).
Ashley, D. J. B. The two 'hit' and multiple 'hit' theories of carcinogenesis. Br. J. Cancer 23, 313–328 (1969).
Ashley, D. J. B. Colonic cancer arising in polyposis coli. J. Med. Genet. 6, 376–378 (1969).
Ichii, S. et al. Inactivation of both APC alleles in an early stage of colon adenomas in a patient with familial adenomatous polyposis (FAP). Hum. Mol. Genet. 1, 387–390 (1992).
Nishisho, I. et al. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 253, 665–669 (1991).
Armitage, P. & Doll, R. A two-stage theory of carcinogenesis in relation to the age distribution of human cancer. Br. J. Cancer 11, 161–169 (1957).
Moolgavkar, S. H. & Venzon, D. J. Two-event model for carcinogenesis: incidence curves for childhood and adult tumors. Mater. Biosci. 47, 55–77 (1979).
Moolgavkar, S. H. & Knudson, A. G. Mutation and cancer: a model for human carcinogenesis. J. Natl Cancer Inst. 66, 1037–1052 (1981).
Nowell, P. C. & Hungerford, D. A. A minute chromosome in human chronic granulocytic leukemia. Science 132, 1497 (1960).
Rowley, J. D. A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 243, 290–293 (1973).
Stehelin, D., Varmus, H. E., Bishop, J. M. & Vogt, P. K. DNA related to the transforming gene(s) of avian sarcoma viruses is present in normal avian DNA. Nature 260, 170–173 (1976).
Shih, C., Shilo, B. Z., Goldfarb, M. P., Dannenberg, A. & Weinberg, R. A. Passage of phenotypes of chemically transformed cells via transfection of DNA and chromatin. Proc. Natl Acad. Sci. USA 76, 5714–5718 (1979).
Dalla-Favera, R. et al. Human c-MYC onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc. Natl Acad. Sci. USA 79, 7824–7827 (1982).
Taub, R. et al. Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells. Proc. Natl Acad. Sci. USA 79, 7837–7841 (1982).
Konopka, J. B., Watanabe, S. M., Singer, J. W., Collins, S. J. & Witte, O. N. Cell lines and clinical isolates derived from Ph1-positive chronic myelogenous leukemia patients express c-ABL proteins with a common structural alteration. Proc. Natl Acad. Sci. USA 82, 1810–1814 (1985).
Shtivelman, E., Lifshitz, B., Gale, R. P. & Canaani, E. Fused transcript of ABL and BCR genes in chronic myelogenous leukaemia. Nature 315, 550–554 (1985).
Stam, K. et al. Evidence of a new chimeric BCR/c-ABL mRNA in patients with chronic myelocytic leukemia and the Philadelphia chromosome. N. Engl. J. Med. 313, 1429–1433 (1985).
Skorski, T. et al. Transformation of hematopoietic cells by BCR/ABL requires activation of a PI-3k/AKT-dependent pathway. EMBO J. 16, 6151–6161 (1997).
Druker, B. J. et al. Effects of a selective inhibitor of the ABL tyrosine kinase on the growth of BCR–ABL positive cells. Nature Med. 2, 561–566 (1996).
Druker, B. J. et al. Activity of a specific inhibitor of the BCR–ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. N. Engl. J. Med. 344, 1038–1042 (2001).
Knudson, A. G. Mutation and cancer: statistical study of retinoblastoma. Proc. Natl Acad. Sci. USA 68, 820–823 (1971).
Hethcote, H. W. & Knudson, A. G. Model for the incidence of embryonal cancers: application to retinoblastoma. Proc. Natl Acad. Sci. USA 75, 2453–2457 (1978).
Comings, D. E. A general theory of carcinogenesis. Proc. Natl Acad. Sci. USA 70, 3324–3328 (1973).
Knudson, A. G. Mutation and human cancer. Adv. Cancer Res. 17, 317–352 (1973).
Knudson, A. G. Retinoblastoma: a prototypic hereditary neoplasm. Semin. Oncol. 5, 57–60 (1978).
Cavenee, W. K. et al. Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature 305, 779–784 (1983).
Francke, U. & Kung, F. Sporadic bilateral retinoblastoma and 13q- chromosomal deletion. Med. Pediatr. Oncol. 2, 379–385 (1976).
Knudson, A. G. Jr,, Meadows, A. T., Nichols, W. W. & Hill, R. Chromosomal deletion and retinoblastoma. N. Engl. J. Med. 295, 1120–1123 (1976).
Friend, S. H. et al. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 323, 643–646 (1986).
Lane, D. P. & Crawford, L. V. T antigen is bound to a host protein in SV40-transformed cells. Nature 278, 261–263 (1979).
Linzer, D. I. & Levine, A. J. Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells. Cell 17, 43–52 (1979).
Finlay, C. A., Hinds, P. W. & Levine, A. J. The p53 proto-oncogene can act as a suppressor of transformation. Cell 57, 1083–1093 (1989).
Malkin, D. et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250, 1233–1238 (1990).
Li, F. P. & Fraumeni, J. F. Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? Ann. Intern. Med. 71, 747–752 (1969).
Yonish-Rouach, E. et al. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 352, 345–347 (1991).
Fukasawa, K., Choi, T., Kuriyama, R., Rulong, S. & Vande Woude, G. F. Abnormal centrosome amplification in the absence of p53. Science 271, 1744–1747 (1996).
Fearon, E. R. & Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell 61, 759–767 (1990).
Kikuchi-Yanoshita, R. et al. Genetic changes of both p53 alleles associated with the conversion from colorectal adenoma to early carcinoma in familial adenomatous polyposis and non-familial adenomatous polyposis patients. Cancer Res. 52, 3965–3971 (1992).
Tomlinson, I. & Bodmer, W. Selection, the mutation rate and cancer: ensuring that the tail does not wag the dog. Nature Med. 5, 11–12 (1999).
Shih, I. M. et al. Evidence that genetic instability occurs at an early stage of colorectal tumorigenesis. Cancer Res. 61, 818–822 (2001).
Stoler, D. L. et al. The onset and extent of genomic instability in sporadic colorectal tumor progression. Proc. Natl Acad. Sci. USA 96, 15121–15126 (1999).
Lengauer, C., Kinzler, K. W. & Vogelstein, B. Genetic instabilities in human cancers. Nature 396, 643–649 (1998).
Loeb, L. A. Mutator phenotype may be required for multistage carcinogenesis. Cancer Res. 51, 3075–3079 (1991).
Bhattacharyya, N. P., Skandalis, A., Ganesh, A., Groden, J. & Meuth, M. Mutator phenotypes in human colorectal carcinoma cell lines. Proc. Natl Acad. Sci. USA 91, 6319–6323 (1994).
Markowitz, S. et al. Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science 268, 1336–1338 (1995).
About this article
Cite this article
Knudson, A. Two genetic hits (more or less) to cancer. Nat Rev Cancer 1, 157–162 (2001). https://doi.org/10.1038/35101031
npj Precision Oncology (2022)
Current Surgery Reports (2022)
Der Urologe (2022)
Mathematical modeling for mutator phenotype and clonal selection advantage in the risk analysis of lung cancer
Theory in Biosciences (2022)
Hereditary pheochromocytoma/paraganglioma syndrome with a novel mutation in the succinate dehydrogenase subunit B gene in a Japanese family: two case reports
Journal of Medical Case Reports (2021)